SEC Form D · Amendment · filed April 16, 2021
Aro Biotherapeutics Co
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Alfredo Marti · Stamford, CTDirectorMark B. Laurenzi · Philadelphia, PAExecBob Vruggink · STEAMBOAT SPRINGS, COExecKevin B. Raidy · Philadelphia, PADirectorSteve S. Deitsch · Fort Collins, COExecC. D. Adair · Nashville, TNDirectorJames A. Mish · BUFFALO, NYExecChristopher B. Mirabelli · Philadelphia, PADirectorCharles R. Conn · Oxford, United KingdomDirectorBruce B. Peacock · Philadelphia, PADirectorHeidi Ridley · Orinda, CADirectorMatthew S. Thompson · Fort Collins, CODirectorBill Butler · LOS ANGELES, CAExec · DirectorMaurcio Bustos · Orinda, CADirectorMichael A. Zercher · BUFFALO, NYDirectorSteven A. Przybyla · BUFFALO, NYDirectorPatricia K. Salame · Oklahoma City, OKDirectorRoger D. O'Brien · BUFFALO, NYDirectorJoshua Goldberg · Baltimore, MDDirectorSusan B. Dillon · Philadelphia, PAExec · DirectorSaan-Chirag B. Gandhi · Philadelphia, PADirectorKevin C. Smith · Denver, COExec · DirectorJamie S. Haggard · Fort Collins, COExec · DirectorTyler Ellison · EGG HARBOR, WIExec · DirectorMarten B. Steen · Philadelphia, PADirectorJess B. Lifton · Philadelphia, PADirectorClifford B. Fleet · BUFFALO, NYDirectorKenneth Ryan · Stamford, CTExecScott B. Greenberg · Philadelphia, PAExecCraig Dickman · GREEN BAY, WIDirectorElizabeth B. Anderson · Philadelphia, PADirectorJohn A. Franzino · BUFFALO, NYDirectorKaryn B. O'Neil · Philadelphia, PAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗